Results 151 to 160 of about 16,733 (229)
The NG-test CARBA 5 and Xpert Carba-R IVD kits were tested against 269 clinical Enterobacterales isolates selected for their previously determined carbapenemase content from the ATLAS Global Surveillance program, primarily from 2020 to 2022 ...
Mark Estabrook +5 more
doaj +1 more source
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians [PDF]
Corcione, Silvia +4 more
core +1 more source
Background: Citrobacter freundii (CFC) and Enterobacter cloacae (ECLC) species complexes represent important causes of hospital-associated infections, frequently are related to outbreaks, and have a great ability to develop antimicrobial resistance.
H. Sader +4 more
semanticscholar +1 more source
Infections caused by MBL-producing Gram-negative bacterial pathogens have disseminated worldwide and are associated with considerable morbidity and mortality.
Matthew E. Falagas +3 more
doaj +1 more source
Stenotrophomonas maltophilia is a multidrug-resistant gram-negative pathogen associated with high morbidity and mortality, especially in immunocompromised patients.
Abdulrahman O Alghamdi +9 more
doaj +1 more source
New β-Lactam/β-Lactamase Inhibitor Combination Antibiotics
The growing problem of infections due to pathogens with antimicrobial resistance, especially Gram-negative bacteria, has led to the development of new β-lactam/β-lactamase inhibitor combination antibiotics.
Maria Sargianou +4 more
doaj +1 more source
Current antimicrobial treatment recommendations for melioidosis, the disease caused by |, are largely based on studies of strains isolated from the Eastern Hemisphere (EH), where most human cases are identified and reported.
core
cdc:109710Correction: Vol. 27, No. 9The acknowledgments and funding information were inaccurate in Severe Acute Respiratory Syndrome Coronavirus 2 in Farmed Mink (Neovison vison), Poland (L. Rabalski et al.). The article has been corrected on-line (https:
core
Background: Aztreonam-avibactam (ATM-AVI) is a promising combination to treat serious infections caused by multi-drug resistant (MDR) pathogens including those producing metallo-β-lactamases (MBLs). The aim of this study was to apply a semi-mechanistic PK/PD modelling approach (Sy et al., CPT Pharmacometrics Syst.
Chauzy, Alexia +8 more
openaire +1 more source

